Literature DB >> 31418522

Serum pentraxin-3 follows a logarithmic distribution particularly at low expected levels.

Ufuk İlgen1, Müçteba Enes Yayla2, Cenk Gökalp3, Hakan Emmungil1, Nurşen Düzgün4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31418522      PMCID： PMC7949185          DOI： 10.1111/iwj.13184

Source DB:  PubMed          Journal:  Int Wound J        ISSN： 1742-4801            Impact factor:   3.315


× No keyword cloud information.
  11 in total

1.  Pentraxin-3: A new parameter in predicting the severity of diabetic foot infection?

Authors:  Safak Ozer Balin; Ayse Sagmak Tartar; Kader Uğur; Faruk Kilinç; Selda Telo; Ali Bal; Mehmet Balin; Ayhan Akbulut
Journal:  Int Wound J       Date:  2019-02-15       Impact factor: 3.315

2.  Severe periodontitis is linked with increased peripheral levels of sTWEAK and PTX3 in chronic migraineurs.

Authors:  Yago Leira; Pablo Ameijeira; Clara Domínguez; Esteban López-Arias; Paulo Ávila-Gómez; María Pérez-Mato; Tomás Sobrino; Francisco Campos; Francesco D'Aiuto; Rogelio Leira; Juan Blanco
Journal:  Clin Oral Investig       Date:  2019-05-20       Impact factor: 3.573

3.  Low serum fibroblast growth factor 2 levels not accompanied by increased serum pentraxin 3 levels in patients with systemic sclerosis.

Authors:  Ufuk İlgen; Müçteba Enes Yayla; Nurşen Düzgün
Journal:  Clin Rheumatol       Date:  2016-11-22       Impact factor: 2.980

4.  Pentraxin-3: A strong novel biochemical marker for appendicitis in children.

Authors:  Mustafa Onur Oztan; Aysegul Aksoy Gokmen; Tunc Ozdemir; Tuba Müderris; Selcuk Kaya; Gokhan Koyluoglu
Journal:  Am J Emerg Med       Date:  2019-01-11       Impact factor: 2.469

5.  Determination of physiological plasma pentraxin 3 (PTX3) levels in healthy populations.

Authors:  Kazumi Yamasaki; Mayumi Kurimura; Takatoshi Kasai; Mina Sagara; Tatsuhiko Kodama; Kenji Inoue
Journal:  Clin Chem Lab Med       Date:  2009       Impact factor: 3.694

6.  Distributions of C-reactive protein measured by high-sensitivity assays in apparently healthy men and women from different populations in Europe.

Authors:  Armin Imhof; Margit Fröhlich; Hannelore Loewel; Nicole Helbecque; Mark Woodward; Phillipe Amouyel; Gordon D O Lowe; Wolfgang Koenig
Journal:  Clin Chem       Date:  2003-04       Impact factor: 8.327

7.  Population distributions of C-reactive protein in apparently healthy men and women in the United States: implication for clinical interpretation.

Authors:  Nader Rifai; Paul M Ridker
Journal:  Clin Chem       Date:  2003-04       Impact factor: 8.327

8.  Pentraxin-3 vs C-reactive protein and other prognostic biomarkers in acute coronary syndrome: A substudy of the Platelet Inhibition and Patients Outcomes (PLATO) trial.

Authors:  Frederic Kontny; Thomas Andersen; Thor Ueland; Axel Åkerblom; Tatevik G Lakic; Annika E Michelsen; Pål Aukrust; Maria Bertilsson; Richard C Becker; Anders Himmelmann; Stefan K James; Agneta Siegbahn; Robert F Storey; Lars Wallentin
Journal:  Eur Heart J Acute Cardiovasc Care       Date:  2019-04-24

9.  Diagnostic value of Pentraxin-3 in patients with sepsis and septic shock in accordance with latest sepsis-3 definitions.

Authors:  Sonja Hamed; Michael Behnes; Dominic Pauly; Dominic Lepiorz; Max Barre; Tobias Becher; Siegfried Lang; Ibrahim Akin; Martin Borggrefe; Thomas Bertsch; Ursula Hoffmann
Journal:  BMC Infect Dis       Date:  2017-08-09       Impact factor: 3.090

10.  Pentraxin-3 Levels Relate to the Wells Score and Prognosis in Patients with Acute Pulmonary Embolism.

Authors:  Haotian Yang; Jun Zhang; Ying Huan; Yawei Xu; Rong Guo
Journal:  Dis Markers       Date:  2019-03-12       Impact factor: 3.434
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.